Shockwave Medical’s Post

The efficacy of GLP-1 medications in managing type 2 #diabetes is well-established in medical literature and clinical practice guidelines. https://bit.ly/3wo1I7A There's less robust support for the widespread use of pharmacotherapy in the treatment of #obesity as a standard of care, although, as with other chronic diseases, some patients may benefit from medications. We explain how to manage your priorities around Rx #benefits, especially GLP-1s. #healthcare

The efficacy of GLP-1 medications in managing type 2 #diabetes is well-established in medical literature and clinical practice guidelines. There's less robust support for the widespread use of pharmacotherapy in the treatment of #obesity as a standard of care, although, as with other chronic diseases, some patients may benefit from medications. We explain how to manage your priorities around Rx #benefits, especially GLP-1s. #healthcare

The efficacy of GLP-1 medications in managing type 2 #diabetes is well-established in medical literature and clinical practice guidelines. https://bit.ly/3UzK2Q5 There's less robust support for the widespread use of pharmacotherapy in the treatment of #obesity as a standard of care, although, as with other chronic diseases, some patients may benefit from medications. We explain how to manage your priorities around Rx #benefits, especially GLP-1s. #healthcare

The efficacy of GLP-1 medications in managing type 2 #diabetes is well-established in medical literature and clinical practice guidelines. https://bit.ly/3J5GePz There's less robust support for the widespread use of pharmacotherapy in the treatment of #obesity as a standard of care, although, as with other chronic diseases, some patients may benefit from medications. We explain how to manage your priorities around Rx #benefits, especially GLP-1s. #healthcare

The efficacy of GLP-1 medications in managing type 2 #diabetes is well-established in medical literature and clinical practice guidelines. https://bit.ly/3JldwKN There's less robust support for the widespread use of pharmacotherapy in the treatment of #obesity as a standard of care, although, as with other chronic diseases, some patients may benefit from medications. We explain how to manage your priorities around Rx #benefits, especially GLP-1s. #healthcare

The efficacy of GLP-1 medications in managing type 2 #diabetes is well-established in medical literature and clinical practice guidelines. There's less robust support for the widespread use of pharmacotherapy in the treatment of #obesity as a standard of care, although, as with other chronic diseases, some patients may benefit from medications. We explain how to manage your priorities around Rx #benefits, especially GLP-1s. #healthcare

The efficacy of GLP-1 medications in managing type 2 #diabetes is well-established in medical literature and clinical practice guidelines. https://bit.ly/3SD8b72 There's less robust support for the widespread use of pharmacotherapy in the treatment of #obesity as a standard of care, although, as with other chronic diseases, some patients may benefit from medications. We explain how to manage your priorities around Rx #benefits, especially GLP-1s. #healthcare

You may have heard about Ozempic and Wegovy — two trending weight loss drugs that are changing the way patients and doctors are tackling the battle of extra weight. A recent UCHealth article features a Q&A with endocrinologist Dr. Cecilia Low Wang about why a newly approved weight loss drug, Zepbound, may work even better than the others. Read the full article here to understand the differences between the drugs, their ingredients, side effects, patient eligibility, and costs. #healthywomenhealthyworld https://lnkd.in/gTggUvrS

The Interesting Case Study "Ankle Venous Ulcers. Double Focal Compression Bandaging" written by Carlos Sánchez Fernández de la Vega* To view the total article click the below link https://lnkd.in/gM2MWzSX Click the below link to view the current issue https://lnkd.in/g-sXcqgX All are invited to submit your article for upcoming issue before July 25, 2024. #casereports #clinicalcase #medicines #casereport #OpenAccess

This week's Clinical Tidbit is on CoQ10 and how it helps the cells in your body. If you take a cholesterol-lowering drug, it may also help with nutrient deficiency issues. Learn more: https://lnkd.in/eji7pPK7